NCT06419946 2026-04-13
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Vastra Gotaland Region
Phase 3 Recruiting
Clinical Trials
67 trialsNCT06618703 2026-04-06
BIChE-1
University Hospital, Angers
Phase NA Recruiting
NCT05805631 2026-03-24
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
Taipei Veterans General Hospital, Taiwan
Phase 2 Recruiting
NCT05954416 2026-02-12
FARD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT07272616 2026-01-30
GDW
Region Stockholm
Recruiting
NCT06898684 2025-12-16
MOVE
Vastra Gotaland Region
Phase NA Recruiting
NCT07264569 2025-12-04
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Henan Cancer Hospital
Phase 1/2 Recruiting
NCT07224451 2025-11-04
BDF002
Sheba Medical Center
Phase NA Recruiting
NCT04324450 2025-09-04
IMPALA
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
NCT02656407 2025-09-02
FUSIMAGINE
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Completed
NCT07100600 2025-08-11
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
Henan Cancer Hospital
Phase 2 Recruiting
NCT04610229 2025-06-12
GLIORAD
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT05474573 2025-05-16
CONFLUENSE
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05475522 2025-05-16
SONOFLUO
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05477680 2025-05-16
BRASH
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05484219 2025-05-16
FUN
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT05484245 2025-05-16
SOMALI
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05485038 2025-05-16
GAMMA
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT06971406 2025-05-14
FLAME-1
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT05700071 2025-03-20
GLIOMRS
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Recruiting
NCT06408428 2025-03-12
MicroECoGG
Institut National de la Santé Et de la Recherche Médicale, France
Phase NA Not yet recruiting
NCT06643000 2025-03-06
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
Henan Cancer Hospital
Phase NA Recruiting
NCT06713395 2024-12-03
Glioma
The Affiliated Brain Hospital of Nanjing Medical University
Phase NA Completed
NCT06559566 2024-08-19
Evaluation of Postoperative Intracranial Pressure in Patients Undergoing Intracranial Tumor Surgery
Bagcilar Training and Research Hospital
Phase NA Not yet recruiting
NCT06441045 2024-06-04
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06051240 2024-04-12
LiBRA
Region Stockholm
Phase 2 Recruiting
NCT06294418 2024-03-05
FCI in Post-operative Low Grade Gliomas
NHS Grampian
Phase NA Unknown
NCT05982691 2023-08-08
Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors
National Cancer Center, Korea
Recruiting
NCT04578691 2022-11-10
Study to Evaluate the Safety and Clinical Outcome of Using Navigation System in Pedicle Screw Placement in Spine Surgery
Taipei Veterans General Hospital, Taiwan
Phase NA Completed
NCT05531695 2022-09-08
ESIBAC
Hull University Teaching Hospitals NHS Trust
Phase NA Completed
NCT05451134 2022-07-12
Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma
China National Center for Cardiovascular Diseases
Unknown
NCT02150564 2022-05-09
SonoRCT
Tata Memorial Hospital
Phase NA Completed
NCT02155452 2022-05-06
ALAglioma
Tata Memorial Hospital
Completed
NCT05082311 2022-02-10
PheoCard
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Completed
NCT05108012 2021-11-22
Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
Royan Institute
Phase 1 Unknown
NCT04778800 2021-08-31
A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
Henan Cancer Hospital
Phase NA Unknown
NCT01703962 2021-08-26
IDASPE
Institut National de la Santé Et de la Recherche Médicale, France
Completed
NCT03888248 2021-03-16
Whole-body Vibration in Children With Neurofibromatosis Type 1
Manchester University NHS Foundation Trust
Phase NA Completed
NCT04174820 2020-11-19
CervIRM
University Hospital, Angers
Unknown
NCT04270461 2020-10-22
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Jiujiang University Affiliated Hospital
Phase 1 Withdrawn
NCT04488783 2020-07-28
Potentiation of Chemotherapy in Brain Tumors by Zinc
Sheba Medical Center
Phase NA Unknown
NCT03010943 2020-04-27
CERVO1
University Hospital, Angers
Phase NA Completed
NCT02246231 2020-03-17
Effect of Implant Position on Magnetic Resonance Image Distortion
Manchester University NHS Foundation Trust
Phase NA Completed
NCT04249921 2020-01-31
Evaluation of Acupuncture Effects for Complications After Surgery of Cerebellopontine Angle Tumor in Skull Base
Taipei Veterans General Hospital, Taiwan
Unknown
NCT03869242 2019-03-11
NovoTTF-200A
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02186262 2018-06-14
RODIG
Turku University Hospital
Completed
NCT02693405 2018-05-03
NEUROCOG-QOL
University Hospital, Angers
Phase NA Unknown
NCT02149459 2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1 Unknown
NCT02029573 2017-08-18
ART
King Fahad Medical City
Phase 2 Completed
NCT02430363 2016-02-24
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Medical Research Council
Phase 1/2 Unknown